6'-(dibutylamino)-3'-methyl-2'-(phenylamino)spiro[isobenzofuran-1(3H),9-(9H)-xanthen]-3-one

Density

Link to relevant study record(s)

Reference

Endpoint:

relative density

Type of information:

experimental study

Adequacy of study:

key study

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

guideline study without detailed documentation

Qualifier:

according to guideline

Guideline:

EU Method A.3 (Relative Density)

GLP compliance:

yes

Type of method:

other: not indicated

Key result

Type:

relative density

Density:

1.19 other: dimensionless

Temp.:

20 °C

Remarks on result:

other: corresponds to D4(20)

Conclusions:

A relative density of 1.19 at 20 °C was determined for the test substance.

Executive summary:

The relative density of the test substance was determined according to EU method A.3 (Huntingdon, ECHA RSS, 2017). The test substance has a relative density of 1.19 at 20 °C.

Description of key information

1.19 at 20 °C

Key value for chemical safety assessment

Relative density at 20C:

1.19

Additional information

In accordance with Article 25(3) of the REACH Regulation the robust study summaries submitted 12 years previously, are used for the purpose of the registration.

A relative density of 1.19 at 20 °C was determined for the test substance in a key study according to EU method A.3 (Huntingdon, ECHA RSS, 2017). In a supporting study a relative density of 1.17 at 20 °C was determined (EU method A.3; air comparison pycnometer) (Safepharm, ECHA RSS, 2017).